ANTIBODIES AGAINST CD79b, DRUG CONJUGATES AND THEIR USE Russian patent published in 2023 - IPC C07K16/18 C07K16/28 C07K16/22 C07K16/46 C12N15/13 C12N15/09 C12N1/19 A61K39/00 A61K39/395 A61P35/00 A61P37/00 

Abstract RU 2805251 C2

FIELD: biotechnology.

SUBSTANCE: following is presented: an anti-CD79b antibody or antigen-binding fragment thereof, a drug conjugate thereof, and their use. The following is also disclosed: a pharmaceutical composition for treating or preventing a disease, a nucleic acid, an expression vector, a cloning vector, a set for treating or preventing a disease mediated by CD79b.

EFFECT: invention makes it possible to use it for the treatment or prevention of a disease mediated by CD79b, as well as in the manufacture of a diagnostic agent for a cell proliferative disorder associated with increased expression of CD79b.

20 cl, 7 dwg, 14 tbl, 7 ex

Similar patents RU2805251C2

Title Year Author Number
ANTI-CD79B ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF 2020
  • Yan, Tsujtsin
  • Tan, Zhenkhun
RU2817143C2
ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE 2019
  • Chen, Yvonne
  • Dennis, Mark
  • Dornan, David
  • Elkins, Kristi
  • Junutula, Jagath, Reddy
  • Polson, Andrew
  • Zheng, Bing
RU2791984C2
TUMOR-TARGETED AGONISTIC CD28-ANTIGEN-BINDING MOLECULES 2019
  • George Guy
  • Hofer Thomas
  • Hosse Ralf
  • Klein Christian
  • Moessner Ekkehard
  • Sam Johannes
  • Umana Pablo
  • Thom Jenny Tosca
  • Gasser Stephan
  • Vallier Jean-Baptiste Pierre
  • Fauti Tanja
RU2808030C2
METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS 2017
  • Chen Vej
  • Mur Pol A.
  • Pandya Naimish Bkharat
  • Bonvini Ezio
  • Vigginton Dzhon Mark
RU2772434C2
BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION 2019
  • Liu Zhigang
  • Hao Xiaobo
  • Liu Yulan
  • Guo Jingjing
RU2764740C1
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF 2020
  • Makdonakh, Sharlott Fenton
  • Panvar, Radzhiv
  • Khekhler, Torsten
  • Kulke, Mikhael
  • Sarma, Ganapati N.
  • Pal, Andreas
  • Myuller, Kristof
  • Simon, Verner
  • Lutts, Kristian
  • Gallo, Francheska
RU2826004C2
RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS 2014
  • Vaskes Maksimiliano
  • Gvchalya Luis
  • Nad Gabor
  • Nad Ester
  • Sijyarto Valeriya
RU2724530C2
ANTIBODIES TO MYOSTATIN, POLYPEPTIDES CONTAINING FC-REGION VARIANTS, AND THEIR APPLICATION METHODS 2016
  • Kuramoti Tajti
  • Igava Tomoyuki
  • Katada Khitosi
  • Khori Yudzi
RU2789884C2
BCMA-TARGETED ANTIBODY AND ITS USE 2018
  • Van, Pen
  • Van, Khuamao
  • Tszyan, Khua
RU2799655C2
PHARMACEUTICAL COMPOSITION, INCLUDING A PH20 VARIANT OF HUMAN HYALURONIDASE, AND A MEDICINAL PRODUCT FOR SUBCUTANEOUS ADMINISTRATION 2020
  • Park, Soon Jae
  • Chung, Hye-Shin
  • Lee, Seung Joo
  • Kim, Kyuwan
  • Byun, Minsoo
  • Nam, Ki Seok
RU2810952C2

RU 2 805 251 C2

Authors

Han Nianhe

Song Liwei

An Deqiang

Zeng Di

Li Huali

Yang Chun

Dates

2023-10-13Published

2019-10-31Filed